Cargando…
Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib
BACKGROUND: Pigmented villonodular synovitis (PVNS) is a rare locally aggressive tumor. PVNS is characterized in most cases by a specific t(1;2) translocation, which fuses the colony stimulating factor-1 (CSF1) gene to the collagen type VIa3 (COL6A3) promoter thus leading through a paracrine effect...
Autores principales: | Stacchiotti, Silvia, Crippa, Flavio, Messina, Antonella, Pilotti, Silvana, Gronchi, Alessandro, Blay, Jean Y, Casali, Paolo G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661378/ https://www.ncbi.nlm.nih.gov/pubmed/23668619 http://dx.doi.org/10.1186/2045-3329-3-8 |
Ejemplares similares
-
Successful treatment of relapsing Pigmented Villonodular Synovitis (PVNS) of the knee with radiosynoviorthesis
por: Costantini, C, et al.
Publicado: (2008) -
Combined Arthroscopic and Endoscopic Synovectomy for Diffuse Pigmented Villonodular Synovitis (PVNS) of the Ankle
por: Lui, Tun Hing, et al.
Publicado: (2022) -
Systematic review: total knee arthroplasty (TKA) in patients with pigmented villonodular synovitis (PVNS)
por: Tan, Yi Chuen, et al.
Publicado: (2021) -
Pigmented Villonodular Synovitis (PVNS) of the Knee mimicking Septic Arthritis in a Paediatric Patient: A Case Report
por: Indra, F, et al.
Publicado: (2021) -
Identification of Patient Needs and Preferences in Pigmented Villonodular Synovitis (PVNS) Using a Qualitative Online Bulletin Board Study
por: Cook, Nigel S., et al.
Publicado: (2020)